CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Piper Sandler Adjusts Price Target on Regeneron Pharmaceuticals to $854 From $855

Neutral
AI Analysis

Summary

Piper Sandler adjusted its price target on Regeneron Pharmaceuticals slightly downward from $855 to $854 per share.

Importance:2/10
Sentiment:
0.00
price_targetanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on July 9, 2026 10:54 AM

Read Original